{"id":"CHEMBL107400","canonicalSmiles":"Cc1cc(OCC(=O)O)cc(C)c1Cc1ccc(O)c(C(C)C)c1","inchiKey":"QNAZTOHXCZPOSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOBETIROME","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GC-1","QRX-431","Sobetirome"],"crossReferences":{"drugbank":["DB07425"],"chEBI":["79988"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1089962","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"RNBGYGVWRKECFJ-ZXXMMSQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUCTOSE 1,6-DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fructose 1,6-diphosphate","Fructose-1,6-Diphosphate"],"crossReferences":{"Wikipedia":["Fructose_1,6-bisphosphate"],"chEBI":["40595"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL109420","canonicalSmiles":"CC(=O)N(C)Cc1cc(C(=O)N(C)Cc2cc3ccccc3n2C)ccc1N","inchiKey":"AWTBJNJPBKTHEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL109420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1094304","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2O)c2ncn(C(C)C)c2n1","inchiKey":"NDUVSANREQEDRE-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOMOUCINE II","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olomoucine Ii"],"crossReferences":{"drugbank":["DB04662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1149","canonicalSmiles":"C[N+](C)(C)C[C@H](O)CC(=O)[O-]","inchiKey":"PHIQHXFUZVPYII-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCARNITINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicarnesine","Biocarn","Carnitor","Carnitor sf","Levocarnitine","Vitamin Bt"],"synonyms":["Carnitine","Carnitine hcl","Carnitine hydrochloride","Levocarnitine","Levocarnitine chloride","Levocarnitine hcl","Levocarnitine hydrochloride","NSC-759132","Oristar lch"],"crossReferences":{"DailyMed":["levocarnitine"],"PubChem":["56320718"],"drugbank":["DB00583"],"chEBI":["16347"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 24 investigational indications."}
{"id":"CHEMBL1159902","canonicalSmiles":"Nc1nc2ncc(COP(=O)(O)O)nc2c(=O)[nH]1","inchiKey":"AJXFJEHKGGCFNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-Hydroxymethylpterin Monophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-Hydroxymethylpterin Monophosphate"],"crossReferences":{"drugbank":["DB03592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200501","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O","inchiKey":"IKDXDQDKCZPQSZ-JHYYTBFNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GOSERELIN ACETATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201247","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novgos","Zoladex","Zoladex la"],"synonyms":["Fertilan","Goserelin Acetate","Goserelin acetate"],"crossReferences":{"DailyMed":["goserelin%20acetate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001065","MONDO_0008170","MONDO_0007254","MONDO_0000521","EFO_0000313","MONDO_0002087","EFO_0000305","MONDO_0008315","EFO_0001663","EFO_0000195","EFO_0000304","MONDO_0002158","EFO_0006861","EFO_0000731","EFO_0000673","MONDO_0024880","EFO_0003922"],"count":18},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1200588","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl","inchiKey":"AUODDLQVRAJAJM-XJQDNNTCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Cleocin hydrochloride","Clindamycin hydrochloride","Dalacin c"],"synonyms":["Antirobe","Clindamycin (as hydrochloride)","Clindamycin HCl","Clindamycin hcl","Clindamycin hydrochloride","Clinsol","Clintabs","NSC-756696","Sobelin","U-25179E"],"crossReferences":{"DailyMed":["clindamycin%20hydrochloride"],"PubChem":["144204142"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200676","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMIC PHOSPHATE P 32","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110568","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chromphosphotope","Phosphocol p32"],"synonyms":["32p","Chromic phosphate p 32","Chromic phosphate p-32","Chromic phosphate p32","Chromic phosphate, p-32","Chromic phosphate,p-32","Phosphocol","Phosphorous (32p) chromicphosphate colloid"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200852","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"HCTVWSOKIJULET-LQDWTQKMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V POTASSIUM","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL615","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beepen VK","Beepen-vk","Betapen-vk","Ledercillin vk","Pen-vee k","Penapar-vk","Penicillin Vk","Penicillin v potassium","Penicillin-vk","Pfizerpen vk","Phenoxymethylpenicillin K","Uticillin vk","V-Cillin-K","V-cillin k","Veetids","Veetids '125'","Veetids '250'","Veetids '500'"],"synonyms":["Antibiocin","NSC-757258","Penicillin potassium phenoxymethyl","Penicillin v potassium","Penicillin v potassium salt","Penicillin vk","Phenoxymethylpenicillin potassium","Potassium penicillin v","Primcillin","Vamosyn"],"crossReferences":{"DailyMed":["penicillin%20v%20potassium"],"PubChem":["144209374","144213231","26757422"],"chEBI":["7967"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL1201080","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cl","inchiKey":"YLCCEQZHUHUYPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Primsol"],"synonyms":["Trimethoprim hcl","Trimethoprim hydrochloride"],"crossReferences":{"DailyMed":["trimethoprim%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1201284","canonicalSmiles":"C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12","inchiKey":"VDHAWDNDOKGFTD-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINACALCET","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sensipar"],"synonyms":["AMG 073","AMG-073","AMG073","Cinacalcet","KRN-1493","KRN1493"],"crossReferences":{"DailyMed":["cinacalcet%20hydrochloride"],"PubChem":["124893630","50125742"],"Wikipedia":["Cinacalcet"],"drugbank":["DB01012"],"chEBI":["48390"]},"childChemblIds":["CHEMBL1200776"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_0001072","EFO_1001173","Orphanet_437","EFO_0008519","EFO_0008506","EFO_0003884","EFO_0000673","EFO_0000313","EFO_1000456","EFO_0003882","EFO_0005754","EFO_1001152"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 5 approved and 8 investigational indications."}
{"id":"CHEMBL1201294","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1","inchiKey":"HYPPXZBJBPSRLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENOXYLATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenoxylate","IDS-ND-016"],"crossReferences":{"DailyMed":["diphenoxylate%20hydrochloride"],"PubChem":["50113007"],"Wikipedia":["Diphenoxylate"],"drugbank":["DB01081"],"chEBI":["4639"]},"childChemblIds":["CHEMBL1200665"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000304","HP_0004798"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201460","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"DALTEPARIN SODIUM","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fragmin","Low liquemine"],"synonyms":[".alpha.-heparin","B01AB04","Boxol","Dalteparin","Dalteparin sodium","FR-860","Fragmine","HEPARIN FRAGMENT KABI 2165","KABI-2165","Low-liquemine"],"crossReferences":{"DailyMed":["dalteparin%20sodium"]},"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0006834","Orphanet_232","EFO_0000681","MONDO_0007254","EFO_0000350","EFO_1002048","EFO_0002950","EFO_1001951","EFO_1001459","MONDO_0008903","EFO_0000712","EFO_0003884","HP_0004419","HP_0004936","EFO_1000158","EFO_0002618","MONDO_0008170","EFO_0004286","EFO_0009315","MONDO_0019514","MONDO_0008315","EFO_0000311","EFO_1000954","HP_0001907","MONDO_0100096","EFO_0003907","EFO_0001378","MONDO_0043510","HP_0004418"],"count":29},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 3 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201479","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYETHYLENE GLYCOL 3350","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycolax","Miralax","Polyethylene glycol 3350"],"synonyms":["Polyethylene glycol 3350"],"crossReferences":{"DailyMed":["polyethylene%20glycol%203350"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for constipation and constipation disorder and has 8 investigational indications."}
{"id":"CHEMBL1201609","drugType":"Protein","blackBoxWarning":false,"name":"CORTICOTROPIN ZINC HYDROXIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortrophin zinc acth","Cortrophin-zinc"],"synonyms":["Corticotrophin zinc hydroxide","Corticotropin zinc hydroxide","Corticotropin-zinc hydroxide"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1201666","drugType":"Protein","blackBoxWarning":false,"name":"LEPIRUDIN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Refludan"],"synonyms":["Hirudin lepirudin","Lepirudin","Lepirudin Recombinant","Lepirudin recombinant"],"crossReferences":{"DrugCentral":["2995"],"Wikipedia":["Lepirudin"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["MONDO_0000831","MONDO_0008903","HP_0004419","HP_0001873"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for recurrent thrombophlebitis and thrombotic disease and has 1 investigational indication."}
{"id":"CHEMBL1201692","drugType":"Protein","blackBoxWarning":false,"name":"FOLLITROPIN ALFA","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bemfola","Follistim","Follistim aq","Gonal-f","Gonal-f rff","Gonal-f rff redi-ject","Ovaleap","Puregon"],"synonyms":["Follitropin alfa","Follitropin alfa/beta","Follitropin beta","Fsh (menotropins)","Human FSH"],"crossReferences":{"DailyMed":["follitropin%20alfa/beta"],"DrugCentral":["4928"]},"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0008560","MONDO_0002775","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 investigational indications."}
{"id":"CHEMBL1201749","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"WYQPLTPSGFELIB-JTQPXKBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLUPREDNATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Durezol"],"synonyms":["Difluprednate","W 6309","W-6309"],"crossReferences":{"DailyMed":["difluprednate"],"PubChem":["144206181","56422387","856020"],"Wikipedia":["Difluprednate"],"drugbank":["DB06781"],"chEBI":["31485"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_1000811","EFO_1001082","EFO_1001231","EFO_1000879","EFO_1000906","MONDO_0005129"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for anterior uveitis and inflammation and has 4 investigational indications."}
{"id":"CHEMBL1213470","canonicalSmiles":"OC[C@H]1N/C(=N/O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"VBXHGXTYZGYTQG-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213470","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02376"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1215661","canonicalSmiles":"N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12","inchiKey":"AQRLDDAFYYAIJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUVANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 390920","EMD-281014","EMD-390920","LSN-2422347","LSN2422347","LY-2420586","LY-2422347","LY-2422347 FREE BASE","LY2420586","LY2422347","Ly2422347","Pruvanserin"],"crossReferences":{"Wikipedia":["Pruvanserin"],"drugbank":["DB13094"]},"childChemblIds":["CHEMBL2104980"],"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1232391","canonicalSmiles":"O[C@H](CS)[C@@H](O)CS","inchiKey":"VHJLVAABSRFDPM-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232391","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01692"],"chEBI":["17456"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232918","canonicalSmiles":"O=C[C@H](O)COP(=O)(O)O","inchiKey":"LXJXRIRHZLFYRP-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232918","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02263"],"chEBI":["29052"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234871","canonicalSmiles":"C=CCNc1ccccc1","inchiKey":"LQFLWKPCQITJIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234871","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02870"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235999","canonicalSmiles":"Nc1ccccc1CO","inchiKey":"VYFOAVADNIHPTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATOIC ANHYDRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isatoic Anhydride"],"crossReferences":{"drugbank":["DB03058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237132","canonicalSmiles":"CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl","inchiKey":"KPBZROQVTHLCDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEVIDIPINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleviprex"],"synonyms":["Clevidepine","Clevidepine butyrate","Clevidipine","Clevidipine butyrate"],"crossReferences":{"DailyMed":["clevidipine"],"PubChem":["170466066"],"drugbank":["DB04920"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_1001031","EFO_0000712","EFO_0004273","EFO_0005669","EFO_0000319","EFO_0001666","EFO_0004264","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL1255582","canonicalSmiles":"CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1","inchiKey":"KXSUAWAUCNFBQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIPAMEZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fipamezole"],"crossReferences":{"drugbank":["DB06585"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1257","canonicalSmiles":"FC(F)OC(F)(F)C(F)Cl","inchiKey":"JPGQOUSTVILISH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENFLURANE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enflurane","Ethrane"],"synonyms":["ANESTHETIC COMPOUND NO. 347","Alyrane","Anesthetic Compound No. 347","Compound 347","Efrane","Enflurane","Methylflurether","NSC-115944","Ohio 347","R-E-235CA2"],"crossReferences":{"PubChem":["144207364","50112675"],"Wikipedia":["Enflurane"],"drugbank":["DB00228"],"chEBI":["4792"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972."}
{"id":"CHEMBL1257073","canonicalSmiles":"O=C(NN1C(=O)[C@H]2[C@H]3C=C[C@H]([C@@H]4C[C@H]34)[C@H]2C1=O)c1ccc(C(F)(F)F)cc1","inchiKey":"CSKDFZIMJXRJGH-VWLPUNTISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECOVIRIMAT","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tpoxx"],"synonyms":["SIGA-246","ST 246","ST-246","Tecovirimat"],"crossReferences":{"DailyMed":["tecovirimat"],"drugbank":["DB12020"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for smallpox and viral disease."}
{"id":"CHEMBL1278118","canonicalSmiles":"COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4cc(F)ccc4nc3OC)CC2)c1","inchiKey":"KAKPGJJRYRYSTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUPINOXIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-p68 inhibitor rx-5902","RX-5902","Rx-5902","Supinoxin"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1410877","canonicalSmiles":"Clc1ccc([C@H](Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1","inchiKey":"JLGKQTAYUIMGRK-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARASERTACONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arasertaconazole","Sertaconazole, (r)-"],"crossReferences":{"PubChem":["11112882"],"chEBI":["83685"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1413199","canonicalSmiles":"O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1","inchiKey":"JYGLAHSAISAEAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENADIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Didandin","Difenadione","Diphacinone","Diphenadione","Diphenylacetylindandione","NCI-9138","NSC-9138","U-1363"],"crossReferences":{"PubChem":["144205446","170466609","26754631","29216237"],"Wikipedia":["Diphenadione"],"drugbank":["DB13347"],"chEBI":["81896"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1484","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"ZBBHBTPTTSWHBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICARDIPINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nicardipine","Nicardipine (stn)","Perpidine"],"crossReferences":{"DailyMed":["nicardipine%20hydrochloride"],"PubChem":["104171201","124880905","144203762","170465173","26755701","26755702","50111158","50111159","90340664"],"Wikipedia":["Nicardipine"],"drugbank":["DB00622"],"chEBI":["7550"]},"childChemblIds":["CHEMBL1200326"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["HP_0000303","HP_0002140","EFO_0001645","EFO_0009846","EFO_0005669","EFO_0000319","EFO_1000994","EFO_0000537","EFO_0000713","EFO_0000712","EFO_0003833","EFO_0000668","EFO_0005672","EFO_0004282","EFO_0007490"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for hypertension and cardiovascular disease and has 11 investigational indications."}
{"id":"CHEMBL1504","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"YNDXUCZADRHECN-JNQJZLCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE ACETONIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"crossReferences":{"DailyMed":["triamcinolone%20acetonide"],"PubChem":["144204436","144208993","144213331","170464660","29215012","56423119","855857"],"Wikipedia":["Triamcinolone_acetonide"],"chEBI":["71418"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0004683","EFO_0010822","HP_0012735","EFO_1000809","EFO_0004274","MONDO_0002959","EFO_0009322","EFO_1001129","EFO_0005773","EFO_0000497","EFO_1000706","EFO_1000680","MONDO_0016047","MONDO_0002471","MONDO_0002280","EFO_1000786","EFO_1001898","EFO_0004616","EFO_0000676","EFO_0004208","EFO_0008517","EFO_1001250","EFO_0004719","EFO_0005854","MONDO_0022113","EFO_0000701","EFO_0007363","HP_0001742","HP_0030016","EFO_1001119","EFO_0000546","EFO_1001231","EFO_1000986","EFO_0004192","EFO_1000049","MONDO_0002406","MONDO_0004979","EFO_0000516","EFO_1001887","EFO_0007415","EFO_1001222","EFO_0003943","EFO_1001998","MONDO_0003005","EFO_1001896","EFO_1001494","EFO_0001365","EFO_0000693","EFO_1001435","EFO_0008507","MONDO_0007254","MONDO_0004037","HP_0010450","MONDO_0002041","EFO_0000274","Orphanet_3437","EFO_0009606","HP_0030834","MONDO_0005129","EFO_0004212","EFO_0004238","EFO_1000726","EFO_0009321","EFO_1001417","EFO_0007490","EFO_0008521","EFO_0000685","EFO_1000616","EFO_1001157","EFO_0003770","EFO_1001054","EFO_0003843","EFO_1000941","EFO_0004229","MONDO_0005301","EFO_0009485","EFO_0000706","MONDO_0005178","MONDO_0004857","EFO_0003956"],"count":80},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 21 approved and 40 investigational indications."}
{"id":"CHEMBL150894","canonicalSmiles":"CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3","inchiKey":"MLIFNJABMANKEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-5214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-5214","Cep-5214"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1580","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O","inchiKey":"FPVKHBSQESCIEP-JQCXWYLXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTOSTATIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nipent","Pentostatin"],"synonyms":["CI-825","Deoxycoformycin","NSC-218321","Nipent","PD 81565","PD-81565","Pentostatin","YK-176"],"crossReferences":{"DailyMed":["pentostatin"],"PubChem":["124893765","144206967"],"Wikipedia":["Pentostatin"],"drugbank":["DB00552"]},"linkedTargets":{"rows":["ENSG00000196839"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0013730","EFO_0000616","EFO_1000956","MONDO_0002280","EFO_0000095","Orphanet_232","EFO_0000574","MONDO_0002367","EFO_0004599","EFO_0000311"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1581","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC","inchiKey":"IPVQLZZIHOAWMC-QXKUPLGCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERINDOPRIL","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MCN-A-2833","Perindopril","S-9490"],"crossReferences":{"DailyMed":["perindopril%20arginine","perindopril%20erbumine"],"PubChem":["144206638","170464836","56463760"],"Wikipedia":["Perindopril"],"drugbank":["DB00790"],"chEBI":["8024"]},"childChemblIds":["CHEMBL3544986","CHEMBL1200343"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003095","EFO_0001645","EFO_0000401","MONDO_0007254","EFO_0001358","EFO_0000319","Orphanet_558","EFO_0000537","EFO_1001480","EFO_1000654","MONDO_0002491","MONDO_0001134","EFO_0003144","EFO_0003884","MONDO_0004975","EFO_0000612","EFO_0004701","MONDO_0005148","EFO_0000407"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1615209","canonicalSmiles":"COCCCOc1ccnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c1C","inchiKey":"YREYEVIYCVEVJK-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRABEPRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexrabeprazole","Rabeprazole, (r)-"],"crossReferences":{"drugbank":["DB13762"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1615775","canonicalSmiles":"O=P(O)(O)C(O)P(=O)(O)O","inchiKey":"HJZKOAYDRQLPME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIDRONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMD-P","HMDP","Oxidronate","Oxidronic acid"],"crossReferences":{"drugbank":["DB14159"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1643895","canonicalSmiles":"Cn1cc(C(=O)[C@@H]2CCc3nc[nH]c3C2)c2ccccc21","inchiKey":"NTHPAPBPFQJABD-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMOSETRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ramosetron"],"crossReferences":{"PubChem":["50112691"],"Wikipedia":["Ramosetron"],"drugbank":["DB09290"]},"childChemblIds":["CHEMBL3181841"],"linkedTargets":{"rows":["ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":5},"linkedDiseases":{"rows":["MONDO_0001056","HP_0005184","EFO_0003931","EFO_0000555","EFO_0004888","EFO_0004616","HP_0002013","EFO_0006912","EFO_0000311","HP_0002018"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1652","canonicalSmiles":"CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl","inchiKey":"OMHBPUNFVFNHJK-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBENONIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ambenonium","Ambenonium cation","Ambenonium ion"],"crossReferences":{"PubChem":["11113478","26756578"],"Wikipedia":["Ambenonium_chloride"],"drugbank":["DB01122"],"chEBI":["2627"]},"childChemblIds":["CHEMBL1200541"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1659","canonicalSmiles":"CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"DBAKFASWICGISY-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE MALEATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allercalm allergy relief","Allerief","Alunex","Antagonate","Calimal","Chlor-trimeton","Chlorphenamine","Chlorpheniramine maleate","Efidac 24 chlorpheniramine maleate","Hayleve","Kloromin","Phenetron","Piriject","Piriton","Piriton allergy","Pyridamal 100","Rhino-syrup allergy","Rimarin","Teldrin"],"synonyms":["(+)-Chlorpheniramine Maleate","Chlorphenamine hydrogen maleate","Chlorphenamine maleate","Chlorphenamini hydrogenomaleas","Chlorpheniramine Maleate","Chlorpheniramine maleate","Chlorprophenpyridamine maleate","Efidac","Histaspan","NSC-756684","Neorestamin","Pyridamal","Synistamin"],"crossReferences":{"DailyMed":["chlorpheniramine%20maleate"],"PubChem":["144209290","144213766","17389966","26719778","50106014","50106015","56422503"],"chEBI":["3645"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007486","HP_0012735","EFO_0003958","MONDO_0004979","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for sinusitis and cough and has 3 investigational indications."}
{"id":"CHEMBL17","canonicalSmiles":"NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1","inchiKey":"GJQPMPFPNINLKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORPHENAMIDE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daranide","Keveyis","Oratrol"],"synonyms":["Dichlorphenamide","Diclofenamide"],"crossReferences":{"DailyMed":["dichlorphenamide"],"PubChem":["11112264","144203952","56463645"],"Wikipedia":["Diclofenamide"],"drugbank":["DB01144"],"chEBI":["101085"]},"linkedTargets":{"rows":["ENSG00000167434","ENSG00000133742","ENSG00000104267","ENSG00000074410"],"count":4},"linkedDiseases":{"rows":["Orphanet_682","Orphanet_681","EFO_0000516","Orphanet_684"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for glaucoma and has 3 investigational indications."}
{"id":"CHEMBL1742996","drugType":"Antibody","blackBoxWarning":true,"name":"BRODALUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kyntheum","Siliq"],"synonyms":["AMG 827","AMG-827","Brodalumab","KHK-4827","KHK4827"],"crossReferences":{"DailyMed":["brodalumab"],"DrugCentral":["5179"]},"linkedTargets":{"rows":["ENSG00000177663"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_1000710","EFO_1001494","EFO_0003898","EFO_0000676","EFO_0003778","MONDO_0004979","Orphanet_163927","EFO_0000540","EFO_0000717","EFO_0000384"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1788387","canonicalSmiles":"CCOCCN(Cc1ccc(CN(CCOCC)C(=O)C(Cl)Cl)cc1)C(=O)C(Cl)Cl","inchiKey":"MSJLJWCAEPENBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECLOZAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Falmonox"],"synonyms":["NSC-107433","Teclozan","WIN 13,146","WIN-13146"],"crossReferences":{"drugbank":["DB13205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL179532","canonicalSmiles":"O=C(O)c1ccc2c(C3CCCCC3)c(-c3ccccc3)n(CC(=O)N3CCOCC3)c2c1","inchiKey":"ZKEZEXYKYHYIMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL179532","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1829433","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)C(c2nc3snc(C)c3c(=O)n2Cc2ccccc2)C(C)C)cc1","inchiKey":"SMFXSYMLJDHGIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4877","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4877","AZD4877","Azd 4877","Azd-4877"],"crossReferences":{"drugbank":["DB11671"]},"linkedTargets":{"rows":["ENSG00000138160"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000574","EFO_0000222","EFO_0000313","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL191598","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)c(COc3cccnc3)c2)[nH]n1","inchiKey":"NTMADESEDXKNFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191598","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL193482","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O","inchiKey":"PROQIPRRNZUXQM-ZXXIGWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRIOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynest","Ortho-gynest","Ovestin","Theelol"],"synonyms":["16.ALPHA.-HYDROXYESTRADIOL","16.alpha.,17.beta.-estriol","Aacifemine","Colpogyn","Estriol","Estriol acetate benzoate","Estriol propionate","Estriol succinate","Incurin","NSC-12169","Oestriol","Trihydroxyestrin"],"crossReferences":{"PubChem":["11532998","144205873","144211921","170465807"],"Wikipedia":["Estriol"],"drugbank":["DB04573"],"chEBI":["27974"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_1001271","EFO_0003103","EFO_0008520","EFO_0003929","EFO_0008522","EFO_0003922","EFO_0002950"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1976040","canonicalSmiles":"C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1","inchiKey":"BKWJAKQVGHWELA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADAVOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 1775","AZD-1775","AZD1775","Adavosertib","Azd-1775","MK-1775","MK1775"],"crossReferences":{"PubChem":["103905025","137276027"],"drugbank":["DB11740"]},"linkedTargets":{"rows":["ENSG00000166483"],"count":1},"linkedDiseases":{"rows":["EFO_1000412","EFO_0001075","EFO_1001958","MONDO_0015686","MONDO_0007254","EFO_1000131","MONDO_0002087","MONDO_0044704","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000043","EFO_0006352","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0000330","MONDO_0044710","EFO_0000707","EFO_1001963","MONDO_0002715","EFO_1000253","EFO_0002618","EFO_0000616","EFO_0000466","EFO_0000503","MONDO_0019457","MONDO_0008170","EFO_0000349","EFO_0002939","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_1000238","EFO_0005537","EFO_0000702","EFO_0001378","MONDO_0024880","EFO_0000519","EFO_0000181","EFO_1000494","EFO_1001960"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL201960","canonicalSmiles":"CCCC(C(=O)c1ccc(C)cc1)N1CCCC1","inchiKey":"SWUVZKWCOBGPTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROVALERONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Misuse"],"year":1979},"tradeNames":[],"synonyms":["J8.659B","Pyrovalerone"],"crossReferences":{"Wikipedia":["Pyrovalerone"]},"childChemblIds":["CHEMBL2104793"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1979 due to Misuse."}
{"id":"CHEMBL2028852","canonicalSmiles":"CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O","inchiKey":"HKMZRZUEADSZDQ-DZJWSCHMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ICATIBANT ACETATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028850","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Firazyr"],"synonyms":["HOE 140","HOE-140","Icatibant acetate"],"crossReferences":{"DailyMed":["icatibant%20acetate"]},"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["MP_0001845","MONDO_0100096","EFO_0005532","Orphanet_91378"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for angioedema and hereditary angioedema and has 2 investigational indications."}
{"id":"CHEMBL2062259","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"TWYFGYXQSYOKLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARENICLINE TARTRATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1396","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Champix","Chantix"],"synonyms":["CP-526,555-18","CP-526555-18","Varenicline tartrate"],"crossReferences":{"DailyMed":["varenicline%20tartrate"]},"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","EFO_0003768","MONDO_0007079"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 investigational indications."}
{"id":"CHEMBL2087337","canonicalSmiles":"CC(C)n1c(=O)c(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21","inchiKey":"HXLOHDZQBKCUCR-WOZUAGRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELUSETRAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TD-5108","Velusetrag"],"crossReferences":{"drugbank":["DB12702"]},"childChemblIds":["CHEMBL2105660"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["HP_0012450","MONDO_0004975","EFO_1000948"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2096637","canonicalSmiles":"C=C/C=C\\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](/C=C(\\C)C(=O)OC)C2(C)C)CC1=O.C=C/C=C\\CC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O","inchiKey":"VXSIXFKKSNGRRO-MXOVTSAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRETHRINS","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pyrethrins"],"crossReferences":{"DrugCentral":["4700"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL2103852","canonicalSmiles":"COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC","inchiKey":"JXONINOYTKKXQQ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROLIBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crolibulin","EPC 2407","EPC-2407","EPC2407"],"crossReferences":{"drugbank":["DB12925"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["MONDO_0002108","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104560","canonicalSmiles":"CCOC(=O)[C@]1(c2ccccc2)CCC=C[C@H]1N(C)C","inchiKey":"WDEFBBTXULIOBB-WBVHZDCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTILIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextilidine"],"crossReferences":{"drugbank":["DB13787"],"chEBI":["77822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105024","canonicalSmiles":"CNC(=O)CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"HHFIATHHSBFCBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOGLICIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ioglicic acid","SH H 200 AB","SH-H-200-AB"],"crossReferences":{"drugbank":["DB13701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105648","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21","inchiKey":"YTFHCXIPDIHOIA-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOVAROTENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sohonos"],"synonyms":["CLM-001","IPN-60120","IPN60120","Palovarotene","R-667","RG-667","RO-3300074","RO3300074"],"crossReferences":{"drugbank":["DB12320"]},"linkedTargets":{"rows":["ENSG00000172819"],"count":1},"linkedDiseases":{"rows":["EFO_1000906","Orphanet_337"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105692","canonicalSmiles":"CC(C)OC(=O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)c1","inchiKey":"NVPXUFQLKWKBHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAPRENEPAG ISOPROPYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04217329","Taprenepag isopropyl"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105987","canonicalSmiles":"CC1=CC(=O)C=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]12C","inchiKey":"PEPMWUSGRKINHX-TXTPUJOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAMESTANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atamestane","SH-489"],"crossReferences":{"drugbank":["DB12194"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106999","canonicalSmiles":"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC3=CCCC3)CC[C@@H]12","inchiKey":"IUVKMZGDUIUOCP-BTNSXGMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINBOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinbolone"],"crossReferences":{"drugbank":["DB13484"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108222","drugType":"Unknown","blackBoxWarning":false,"name":"ALOXIPRIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Palaprin fte"],"synonyms":["Alaprin","Aloxiprin","Paloxin","Polyoxyaluminum acetylsalicylate","Superpyrin"],"crossReferences":{"DrugCentral":["4760"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0001945","HP_0004419","EFO_0003843"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL2108340","drugType":"Protein","blackBoxWarning":false,"name":"TRIDECACTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.1-13-acth","Alpha-1-13-corticotropin, human","Tridecactide"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108669","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 TACATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Afp-cide"],"synonyms":["HAFP-31","Yttrium (90y) tacatuzumab tetraxetan","Yttrium y 90 tacatuzumab tetraxetan"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108684","drugType":"Unknown","blackBoxWarning":false,"name":"NELIPEPIMUT-S","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["E75 peptide"],"synonyms":["E-75 PEPTIDE","E75 PEPTIDE","Her2 369-377","Nelipepimut s","Nelipepimut-s","Neuvax"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108700","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUCOSE OXIDASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COMPONENT OF E-101","E.C. 1.1.3.4","GO","GO; COMPONENT OF E-101","Glucose oxidase"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108767","drugType":"Antibody","blackBoxWarning":false,"name":"RUPLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Antova"],"synonyms":["BG-9588","BG9588","HU-5C8","Ruplizumab","hu5c8"],"linkedTargets":{"rows":["ENSG00000102245"],"count":1},"linkedDiseases":{"rows":["EFO_0005761"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109042","drugType":"Unknown","blackBoxWarning":false,"name":"INFLUENZA VIRUS VACCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluogen","Flushield","Fluzone"],"synonyms":["Influenza virus vaccine","Influenza, live attenuated"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL2109413","drugType":"Antibody","blackBoxWarning":false,"name":"AS-1409","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1409","As-1409","HUBC1-HUIL12"],"linkedTargets":{"rows":["ENSG00000115414"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000681"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109435","drugType":"Antibody","blackBoxWarning":false,"name":"HUA33","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUA33","Hua33"],"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_0004142","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110756","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C(C)C)[C@H]2O)[C@@]2(C)CC(C)=C(O2)[C@H](C)C(=O)[C@]1(C)OC","inchiKey":"BELMMAAWNYFCGF-PZXAHSFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITEMCINAL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mitemcinal"],"crossReferences":{"drugbank":["DB06587"]},"childChemblIds":["CHEMBL2105890"],"linkedTargets":{"rows":["ENSG00000102539"],"count":1},"linkedDiseases":{"rows":["EFO_1000948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL213907","canonicalSmiles":"COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"LEQAKWQJCITZNK-AXHKHJLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213907","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204021"],"drugbank":["DB11582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146063","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl","inchiKey":"CBHYYLPALVVVEY-MRFRVZCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTETRACYCLINE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL404520","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aureomicina","Aureomycin","Chlortet hcl","Fermycin","Isaphamycin"],"synonyms":["Aureomycin monohydrochloride","Chlortetracycline hcl","Chlortetracycline hydrochloride","Chlortetracyclini hydrochloridum","Isphamycin","NSC-13252"],"crossReferences":{"PubChem":["144203904","144212027"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950."}
{"id":"CHEMBL2165191","canonicalSmiles":"Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1","inchiKey":"IRTDIKMSKMREGO-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-6482","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-6482","AZD6482","Azd 6482","Azd-6482"],"crossReferences":{"drugbank":["DB14980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219416","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O","inchiKey":"MNYIRXLCPODKLG-VUTNLTPYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXEGOL OXALATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219418","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Movantik"],"synonyms":["AZ13337019 oxalate","NKTR-118 oxalate","Naloxegol oxalate"],"crossReferences":{"DailyMed":["naloxegol%20oxalate"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843","MONDO_0002203"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for constipation disorder and pain."}
{"id":"CHEMBL223643","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC(=O)[C@H](C(C)C)NC(=O)[C@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](C(C)C)OC1=O","inchiKey":"FCFNRCROJUBPLU-DNDCDFAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALINOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valino","Valinomycin"],"crossReferences":{"drugbank":["DB14057"],"chEBI":["28545"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2336071","canonicalSmiles":"CCc1cc(/C(C)=N/OCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1","inchiKey":"KIHYPELVXPAIDH-HNSNBQBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIPONIMOD","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAF-312","BAF312","Baf312","NVP-BAF312-NX","Siponimod"],"crossReferences":{"DailyMed":["siponimod%20fumaric%20acid"],"drugbank":["DB12371"]},"childChemblIds":["CHEMBL4298150"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003840","MONDO_0005301","EFO_0000398","EFO_0001421","EFO_0003929","EFO_0003063","EFO_0000540","EFO_0008522"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 4 approved and 7 investigational indications."}
{"id":"CHEMBL2348780","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"ZYTXTXAMMDTYDQ-DGEXFFLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2348780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2369989","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)[N+](C)(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O","inchiKey":"DUQRILZXKXSRIY-RUBJUKRASA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATILMOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atilmotin","BAX-ACC-1638","MOT-288","OHM-11638"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL241577","canonicalSmiles":"O=C(O)COc1cc(Cl)ccc1C(=O)NCc1cccc([N+](=O)[O-])c1","inchiKey":"VABIMMIJVWNHFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL241577","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243716","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@H]1CC[C@@H](CO)O1","inchiKey":"FJAOCNGVPLTSLD-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METACAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metacavir"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL253592","canonicalSmiles":"CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1","inchiKey":"RYOOHIUJEJZCFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMYLOFIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acamylophenine","Acamylophenine hydrochloride","Anafortan","Camylofin"],"crossReferences":{"PubChem":["144205710","170465936","26757945"],"drugbank":["DB13738"]},"childChemblIds":["CHEMBL4303602"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL257036","canonicalSmiles":"NCc1ccccc1-c1ccccc1","inchiKey":"YHXKXVFQHWJYOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Phenylbenzylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenylbenzylamine"],"crossReferences":{"drugbank":["DB07412"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257626","canonicalSmiles":"C[C@@](N)(C(=O)O)c1ccc(C(=O)O)cc1","inchiKey":"DNCAZYRLRMTVSF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111462","11113453","11113454","26751683"],"drugbank":["DB04256"],"chEBI":["43876"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288149","canonicalSmiles":"CC(=O)NC[C@H]1CN(c2ccc(N3CCSCC3)c(F)c2)C(=O)O1","inchiKey":"FNDDDNOJWPQCBZ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUTEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-742407","Oxazolidininone","PNU-100480","Sutezolid","U 100480","U-100480"],"crossReferences":{"drugbank":["DB11905"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL293212","canonicalSmiles":"N=C(Nc1ccc(CCNCc2cccc(Cl)c2)cc1)c1cccs1","inchiKey":"ZZVGLDBDDYESAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293212","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03449"]},"childChemblIds":["CHEMBL3216853"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30116","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21","inchiKey":"JOHZPMXAZQZXHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPEMIDIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pipram"],"synonyms":["Deblaston","Dolcol","Filtrax","Memento 400","NSC-758160","Nuril","Pi-coli","Pipeacid","Pipedac","Pipemid","Pipemidate","Pipemidic acid","Pipemidic acid anhydrous","Pipemidic acid hydrate","Pipemidic acid trihydrate","Pipurin","Tractur","Uropimid","Urosten","Uroval"],"crossReferences":{"PubChem":["11112780","144204206","170465767","855987"],"Wikipedia":["Pipemidic_acid"],"drugbank":["DB13823"],"chEBI":["75250"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL303933","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1","inchiKey":"UCRHFBCYFMIWHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine","Piperaquinoline"],"crossReferences":{"Wikipedia":["Piperaquine"],"drugbank":["DB13941"]},"childChemblIds":["CHEMBL539666","CHEMBL1652442"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3039522","canonicalSmiles":"CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12","inchiKey":"PKWRMUKBEYJEIX-DXXQBUJASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRINAPANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birinapant","TL-32711","TL32711"],"crossReferences":{"drugbank":["DB11782"]},"linkedTargets":{"rows":["ENSG00000110330","ENSG00000023445"],"count":2},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000616","EFO_0000198","EFO_1001958","MONDO_0015686","MONDO_0008170","EFO_0000222","EFO_0004197","EFO_0000311","MONDO_0002158","EFO_1001100","EFO_1000251","EFO_0000181","EFO_1000494"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3092041","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"LGGDXXJAGWBUSL-BKRJIHRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLDIHYDROCODEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetyldihydrocodeine"],"crossReferences":{"drugbank":["DB01538"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3142541","canonicalSmiles":"CCCCOC(=O)c1ccc(N)cc1.CCCCOC(=O)c1ccc(N)cc1.O=[N+]([O-])c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1","inchiKey":"ATAGSVCDFKGYPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAMBEN PICRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL127516","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"," Psychiatric toxicity"],"year":1964},"tradeNames":[],"synonyms":["ABBOTT-34842","Butamben picrate"],"crossReferences":{"chEBI":["86300"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1964 due to Dermatological toxicity and  Psychiatric toxicity."}
{"id":"CHEMBL3286830","canonicalSmiles":"C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21","inchiKey":"IIXWYSCJSQVBQM-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORLATINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lorbrena"],"synonyms":["Lorlatinib","PF-06463922"],"crossReferences":{"DailyMed":["lorlatinib"],"drugbank":["DB12130"]},"childChemblIds":["CHEMBL4539157"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000143924"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0003032","EFO_0001421","EFO_0000574","EFO_0003060","EFO_0000621","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL3301587","drugType":"Antibody","blackBoxWarning":false,"name":"DURVALUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imfinzi"],"synonyms":["Durvalumab","MEDI-4736","MEDI4736"],"crossReferences":{"DailyMed":["durvalumab"]},"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0000365","EFO_0001075","MONDO_0003890","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1000657","EFO_0005952","EFO_0000228","MONDO_0044704","EFO_1001951","MONDO_0003059","EFO_0000588","EFO_0009709","MONDO_0002974","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","EFO_0000501","MONDO_0003199","EFO_0000641","EFO_0000514","MONDO_0003001","MONDO_0021115","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0001642","MONDO_0002108","MONDO_0008170","EFO_0003017","EFO_1001973","EFO_0000349","EFO_0005842","EFO_1001968","MONDO_0004986","EFO_0002429","MONDO_0008315","EFO_0005221","EFO_0000294","MONDO_0044889","EFO_0003868","EFO_0005537","EFO_0004284","EFO_0000574","EFO_0006544","EFO_0001378","EFO_0000563","EFO_0000348","MONDO_0044903","MONDO_0021117","EFO_0002913","MONDO_0044887","MONDO_0007254","EFO_0004230","EFO_1001012","EFO_0000708","EFO_0000305","MONDO_0020654","MONDO_0001187","EFO_0002430","MONDO_0001056","EFO_1001480","EFO_1000044","EFO_0003968","MONDO_0002898","EFO_0000770","EFO_0000673","EFO_0000707","EFO_0000616","EFO_0003897","MONDO_0021656","EFO_0006859","EFO_0005220","EFO_0000503","EFO_0000478","EFO_0000403","MONDO_0003002","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0006738","EFO_1001961","EFO_0000640","EFO_0003863","EFO_0000095","MONDO_0021148","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_0000199","MONDO_0018906","EFO_0003050","EFO_0000691","EFO_0000181","EFO_0000519","MONDO_0024880"],"count":104},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 10 approved and 77 investigational indications."}
{"id":"CHEMBL3306201","canonicalSmiles":"CN(C)C=Nc1c(I)cc(I)c(CCC(=O)O)c1I","inchiKey":"YQNFBOJPTAXAKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3306201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09333"]},"childChemblIds":["CHEMBL3184539"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3355009","canonicalSmiles":"CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(C(C)(C)C(F)(F)F)on2)c(F)c1","inchiKey":"IDXKJSSOUXWLDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-3179106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3179106","Gsk-3179106","Gsk3179106"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL351769","canonicalSmiles":"Nc1ccc([As](=O)(O)O)cc1","inchiKey":"XKNKHVGWJDPIRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSANILIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arsanilic acid"],"crossReferences":{"PubChem":["144204755","144211760","170465635","26753349","26753350","29215145","56422181","68723","8139922"],"Wikipedia":["Arsanilic_acid"],"drugbank":["DB03006"],"chEBI":["49477"]},"childChemblIds":["CHEMBL3188525"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544998","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3007113","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-3007113"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MONDO_0024880"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545001","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8353","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-8353","SCH-900353"],"linkedTargets":{"rows":["ENSG00000102882","ENSG00000100030"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545039","canonicalSmiles":"Cc1cc(Cl)cc2c1N(Cc1cccc(C(F)(F)F)c1)C(=O)C21NC(=O)NC1=O","inchiKey":"DXDVSYALLVVBOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1386","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1386","Azd 1386","Azd-1386","Azd1386"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0012532","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545097","canonicalSmiles":"CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21","inchiKey":"GYLDXIAOMVERTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPANISERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INK-128","INK128","Ink-128","MLN-0128","MLN0128","Mln-0128","Sapanisertib","TAK-228"],"crossReferences":{"drugbank":["DB11836"]},"childChemblIds":["CHEMBL3943182"],"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0007416","MONDO_0015686","EFO_0000681","EFO_1000231","MONDO_0007254","EFO_1001465","EFO_0004230","MONDO_0004222","EFO_0000708","EFO_0000209","MONDO_0003541","EFO_1000043","EFO_1000251","EFO_0000182","EFO_1001963","EFO_1000045","EFO_0009441","EFO_0000616","EFO_0000466","MONDO_0002108","EFO_1001968","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001471","EFO_1000238","EFO_0000574","EFO_0006544","EFO_0001378","EFO_0000519"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL3545125","canonicalSmiles":"CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O","inchiKey":"FTBQORVNHOIASH-CKYFFXLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIROGABALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-200-0700","A200-0700","Mirogabalin"],"crossReferences":{"drugbank":["DB11825"]},"childChemblIds":["CHEMBL3545257"],"linkedTargets":{"rows":["ENSG00000007402","ENSG00000153956"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","EFO_0005687","MONDO_0041052","HP_0001945","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL367788","canonicalSmiles":"O=C(NO)c1ccc(O)c(O)c1","inchiKey":"QJMCKEPOKRERLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-324360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-324360"],"crossReferences":{"PubChem":["457824"],"drugbank":["DB12948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707293","drugType":"Small molecule","blackBoxWarning":false,"name":"XEN-D0501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xen-d0501"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["HP_0012735","EFO_0000341","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707341","canonicalSmiles":"CBr.CN(C)CCOC(c1ccccc1)c1ccccc1","inchiKey":"RSABECAAVLQBOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE METHYLBROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diphenhydramine methylbromide","Mefenidramium bromide","Paradryl"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707447","canonicalSmiles":"CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Ca+2]","inchiKey":"JWLAOERSRUNGEF-JQVJEGKNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM PANGAMATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707449","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium pangamate","Pangamate calcium","Pangamic acid, calcium salt"],"crossReferences":{"DrugCentral":["4385"],"drugbank":["DB13590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3818130","canonicalSmiles":"CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O","inchiKey":"FQVLRGLGWNWPSS-BXBUPLCLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ADH-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adh 1","Adh-1","Cys-his-ala-val-cys","Exherin","NSC-729477"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833336","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)[O-].CC(C)(Oc1ccc(Cl)cc1)C(=O)[O-].[Al+3].[OH-]","inchiKey":"USWVMPGQVYZHCA-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM CLOFIBRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL683","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium clofibrate","Aluminum clofibrate"],"crossReferences":{"DrugCentral":["4437"],"drugbank":["DB13780"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833386","drugType":"Cell","blackBoxWarning":false,"name":"GALINPEPIMUT-S","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Galinpepimut-s","SLS-001"],"linkedTargets":{"rows":["ENSG00000184937"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL392149","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3c(N[C@@H]4CCOC4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"OESBDSFYJMDRJY-BAYCTPFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECADENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVT-510","Tecadenoson"],"crossReferences":{"drugbank":["DB04954"]},"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3924132","canonicalSmiles":"CCOc1cc(-c2nncn2C)ccc1Nc1ncc2cc(C)nc(NCC(C)(C)C)c2n1","inchiKey":"SGWLRDAOCLITOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3924132","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15498"]},"childChemblIds":["CHEMBL4242594"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL39560","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2","inchiKey":"NOSIYYJFMPDDSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEPROMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acepromazine","Acetylpromazine","Acezine 2","Atravet","Concentrat vo34"],"crossReferences":{"PubChem":["11112541"],"Wikipedia":["Acepromazine"],"drugbank":["DB01614"],"chEBI":["44932"]},"childChemblIds":["CHEMBL1883146"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989515","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.O.O.O.O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"WIDKTXGNSOORHA-CJHXQPGBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENICILLIN G BENZATHINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicillin","Bicillin l-a","Bicillin l-a tubex","Extencilline","Penadur 6-3-3","Penidural","Penidural la","Permapen","Retarpen"],"synonyms":["Benzacillin","Benzapen","Benzathin penicillin g","Benzathine benzylpenicillin","Benzathine penicillin","Benzathini benzylpenicillinum","Benzethacil","Benzilpenicillina benzatinica","Benzylpenicillin benzathine","Benzylpenicillin benzathine hydrate","Bica-penicillin","Cillenta","Debecillin","Duropenin","Lentocillin","Leomypen","Longacilina","Longicil","Moldamin","Neolin","Pen-di-ben","Penadur","Pendepon","Penditan","Penicillin g benzathine","Penidure","Vicin","Wycillina"],"crossReferences":{"DailyMed":["penicillin%20g%20benzathine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for bacterial disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL417016","canonicalSmiles":"OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"GUBGYTABKSRVRQ-DCSYEGIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTOSE, ANHYDROUS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous lactose","Lactopress anhydrous","Lactose","Lactose anhydrous","Lactose, anhydrous","Lactose, unspecified form","Lactose,anhydrous","Lactose-electricitas","Lactosum, anhydrous","Milk sugar","Saccharum lactis","Supertab 21an","Supertab 22an","Supertab 24an"],"crossReferences":{"PubChem":["144212183"],"Wikipedia":["Lactose"],"chEBI":["36218"]},"childChemblIds":["CHEMBL2106323"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 29 investigational indications."}
{"id":"CHEMBL42126","canonicalSmiles":"COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1","inchiKey":"RRRUXBQSQLKHEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLAMILAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piclamilast","RP 73401","RP-73041","RP-73401","RP73401","RPR-73401"],"crossReferences":{"Wikipedia":["Piclamilast"],"drugbank":["DB01791"],"chEBI":["47619"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428495","canonicalSmiles":"O=C(O)Cc1cccc2ccccc12","inchiKey":"PRPINYUDVPFIRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Naphthalen-1-ylacetic acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naphthalen-1-ylacetic acid"],"crossReferences":{"PubChem":["144204602","144213968","170466030","17389810","26752862","49825821"],"Wikipedia":["1-Naphthaleneacetic_acid"],"drugbank":["DB01750"],"chEBI":["32918"]},"childChemblIds":["CHEMBL3559962"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297107","canonicalSmiles":"CC(C)N1CC(O)C2=CC(=NNC(N)=O)C(=O)C=C21","inchiKey":"XZKVIDLLLOUTSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAZOCHROME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Divascan","Iprazochrome","NSC-10065"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297618","canonicalSmiles":"CCOC(=O)C(COC(=O)Cc1ccc(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)c(C(=O)N(C)C)c1)(C(=O)OCC)c1ccccc1","inchiKey":"FPUQGCOBYOXAED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANOTAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Granotapide","JTT-130","Jtt-130"],"crossReferences":{"drugbank":["DB12934"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298004","drugType":"Antibody","blackBoxWarning":false,"name":"VOPRATELIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-icos agonist mab jtx-2011","JTX-2011","Jtx 2011","Jtx-2011","Vopratelimab"],"linkedTargets":{"rows":["ENSG00000163600"],"count":1},"linkedDiseases":{"rows":["EFO_0003060","EFO_0000311"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298030","drugType":"Protein","blackBoxWarning":false,"name":"EFGIVANERMIN ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efgivanermin alfa","MEDI-1873","MEDI1873","Medi 1873","Medi1873"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL433501","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3ccccc3O)nc2c1","inchiKey":"URJKRCBBKTXOHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL433501","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455477","canonicalSmiles":"C=CC1=C(C)/C(=C/C2=N/C(=C\\c3[nH]c(/C=C4\\NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)C(CCC(=O)O)=C2C)NC1=O","inchiKey":"QBUVFDKTZJNUPP-BBROENKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILIVERDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biliverdin"],"crossReferences":{"Wikipedia":["Biliverdin"],"drugbank":["DB02073"],"chEBI":["17033"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458876","canonicalSmiles":"Nc1nc(N)c2ncn([C@H]3CO[C@@H](CO)O3)c2n1","inchiKey":"RLAHNGKRJJEIJL-RFZPGFLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMDOXOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-DAPD","Amdoxovir","DAPD"],"crossReferences":{"Wikipedia":["Amdoxovir"],"drugbank":["DB06619"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594257","canonicalSmiles":"CCOC(=O)[C@H](C)N[P@](=O)(CO[C@@H]1C=C(F)[C@H](n2cnc3c(N)ncnc32)O1)Oc1ccccc1","inchiKey":"OCJRRXHWPBXZSU-BNCZGPJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVAFOVIR ETALAFENAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9131","GS-9148 PHOSPHONOAMIDATE PRODRUG","GS9131","Gs-9131","Rovafovir etalafenamide"],"childChemblIds":["CHEMBL4594289"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594274","canonicalSmiles":"Cc1c(-c2cc(C(=O)O)c3c(O[C@H](C)C4CCOCC4)ccc(C)c3n2)oc2ccccc12","inchiKey":"QUDOHCFOJCNKPK-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSENACAFTOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTI-801","Posenacaftor"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594568","drugType":"Unknown","blackBoxWarning":false,"name":"KN-026","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anbenitamab","Anti-her2 bsab kn026","KN-026","KN026","Kn-026","Kn026"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650317","canonicalSmiles":"CC(C)(C)CNCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21","inchiKey":"UYODNJZBUUEXPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICAPAMESPIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Icapamespib","PU-HZ151"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650338","canonicalSmiles":"CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1","inchiKey":"DNPOFZXZJJDQLB-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDRALBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edralbrutinib","SHR-1459","SHR1459","Shr1459","TG-1701","TG1701","Tg-1701"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650366","canonicalSmiles":"Cn1cc(-c2cc(S(C)(=O)=O)ccc2OCC2CC2)c2ccccc2c1=O","inchiKey":"UWZAJPITKGWMFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROTABRESIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bet inhibitor cc-90010","CC-90010","Cc-90010","QC5487","Trotabresib"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650457","drugType":"Unknown","blackBoxWarning":false,"name":"ZETELETINIB HEMIADIPATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BOS-172738","BOS172738","BOS172738 HEMIADIPATE","Bos172738","DS-5010","DS5010","Zeteletinib hemiadipate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650459","drugType":"Unknown","blackBoxWarning":false,"name":"PLAZINEMDOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAD-9303","Cad-9303","Plazinemdor"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802198","drugType":"Antibody","blackBoxWarning":false,"name":"QUISOVALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEVI-002","CERC-002","Cerc-002","Mdgn-002","Quisovalimab","SAR-252067","SAR252067"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL482967","canonicalSmiles":"Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1","inchiKey":"GPSZYOIFQZPWEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYC-116","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYC-116","Cyc 116","Cyc-116"],"crossReferences":{"PubChem":["103904403","137276048"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000178999","ENSG00000105146"],"count":4},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL485629","canonicalSmiles":"O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O","inchiKey":"JJWKQXNHYDJXKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0873","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0873","MK0873","Mk-0873"],"crossReferences":{"drugbank":["DB13029"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL487739","canonicalSmiles":"COc1ccc(CCc2c3nc[nH]c3cc3c(=O)[nH]c(N)nc23)cc1","inchiKey":"UKRVQKUVWNDGMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL504567","canonicalSmiles":"O=c1ncccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"RPQZTTQVRYEKCR-WCTZXXKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZEBULARINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zebularine"],"crossReferences":{"drugbank":["DB03068"],"chEBI":["46938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521686","canonicalSmiles":"O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1","inchiKey":"FDLYAMZZIXQODN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLAPARIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lynparza"],"synonyms":["AZ-2281","AZ2281","AZD-2281","AZD2281","KEYLYNK-010 COMPONENT OLAPARIB","KU-0059436","KU-59436","NSC-747856","OLAPARIB COMPONENT OF KEYLYNK-010","Olaparib"],"crossReferences":{"DailyMed":["olaparib"],"PubChem":["124947876","164339421","174007124"],"Wikipedia":["Olaparib"],"drugbank":["DB09074"],"chEBI":["83766"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001361","EFO_0000637","EFO_0001075","EFO_1001958","EFO_0000681","EFO_1000984","EFO_1001951","MONDO_0003059","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_1000251","EFO_0002918","EFO_0000514","MONDO_0002715","EFO_0002618","EFO_0000216","Orphanet_145","EFO_0003893","MONDO_0008170","EFO_1001512","EFO_1001968","MONDO_0008315","EFO_0005221","EFO_0001663","EFO_0009708","EFO_0000294","Orphanet_398934","EFO_0001061","EFO_1001100","EFO_1000238","EFO_0005537","EFO_0000574","EFO_0006544","MONDO_0002928","MONDO_0100342","MONDO_0015686","EFO_1001901","MONDO_0007254","EFO_0004230","MONDO_0002087","EFO_0000305","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_1000044","EFO_0003968","EFO_0003860","EFO_1001974","EFO_0000673","EFO_0000196","EFO_0000326","EFO_0000707","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0006859","EFO_0000503","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0000174","EFO_0002517","MONDO_0011962","EFO_0000702","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519"],"count":74},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 6 approved and 55 investigational indications."}
{"id":"CHEMBL564912","canonicalSmiles":"O=C1CCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl","inchiKey":"VXIYTVJEIXMAQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL564912","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58910","canonicalSmiles":"O=C(O)[C@@H](O)c1ccccc1","inchiKey":"IWYDHOAUDWTVEP-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Hydroxy-Phenyl-Acetic Acid Anion","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxy-Phenyl-Acetic Acid Anion"],"crossReferences":{"PubChem":["11532933","26513820"],"drugbank":["DB03357"],"chEBI":["32800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL65553","canonicalSmiles":"C=CCN(C)C/C=C/COc1ccc2c(-c3ccc(Br)cc3)coc2c1","inchiKey":"KCNKJCHARANTIP-SNAWJCMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL65553","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03771"]},"childChemblIds":["CHEMBL481811"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL68055","canonicalSmiles":"CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21","inchiKey":"DUYNJNWVGIWJRI-LJAQVGFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOLBIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acolbifene","Em-652","SCH-57068","SCH57068"],"childChemblIds":["CHEMBL2105965"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL70","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5","inchiKey":"BQJCRHHNABKAKU-KBQPJGBKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORPHINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anhydrous morphine","Avinza","Depodur","Hydromorphone hydrochloride impurity, morphine-","IDS-NM-009","Infumorph","Kadian","Morphia","Morphine","Morphine (anhydrous)","Morphine anhydrous","Morphine extended release","Morphine polistirex","Morphium","N02AA01","Nepenthe","Ospalivina"],"crossReferences":{"DailyMed":["morphine%20sulfate"],"Wikipedia":["Morphine"],"drugbank":["DB00295"],"chEBI":["17303"]},"childChemblIds":["CHEMBL2096625","CHEMBL4068407","CHEMBL2103744","CHEMBL556578"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0024647","EFO_0001361","EFO_0003777","HP_0000989","EFO_0000540","HP_0011868","HP_0004798","EFO_1001951","EFO_0003964","EFO_0003913","EFO_0009727","EFO_0003931","EFO_0009513","EFO_0004253","EFO_1001898","EFO_1000786","EFO_1001134","EFO_0004616","HP_0003419","HP_0008419","EFO_0005799","EFO_0009620","EFO_0003877","EFO_1001250","EFO_0005762","EFO_0001074","HP_0012532","EFO_0005323","EFO_0009516","MONDO_0008315","HP_0002027","EFO_0000546","HP_0100806","MP_0001914","MONDO_0001208","HP_0003040","EFO_0009688","EFO_0009842","EFO_0004888","EFO_0000341","EFO_0005672","EFO_1001792","EFO_1001998","MONDO_0000726","EFO_0004240","Orphanet_232","EFO_0007453","EFO_0000768","EFO_0004992","MONDO_0007254","MONDO_0005271","EFO_0009267","MONDO_0004565","EFO_0002950","MONDO_0001056","EFO_0005279","EFO_0003917","HP_0001822","EFO_0000616","EFO_0004210","EFO_0009816","EFO_0001645","HP_0011110","EFO_0000222","HP_0003418","EFO_0003818","EFO_0010702","EFO_0001073","EFO_0003843","EFO_0005755","HP_0002315","EFO_0000311","EFO_0007149","EFO_1001412","EFO_0003890","EFO_0004273","EFO_0008583","EFO_0000612","EFO_0005611","EFO_0009314","EFO_0004270","EFO_0003918","MONDO_0005178","MONDO_0024880","HP_0002019","GO_0035483","EFO_0009492","EFO_0003833"],"count":88},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 4 approved and 47 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL78755","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(S(N)(=O)=O)cc2)cc1","inchiKey":"HDCXQTPVTAIPNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL78755","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08301"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7942","canonicalSmiles":"O=C(O)CC(=O)O","inchiKey":"OFOBLEOULBTSOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207732"],"Wikipedia":["Malonic_acid"],"drugbank":["DB02175"],"chEBI":["30794"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL82411","canonicalSmiles":"O=C(O)Cc1c[nH]c2ccccc12","inchiKey":"SEOVTRFCIGRIMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE-3-ACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole-3-Acetic Acid"],"crossReferences":{"PubChem":["144209482","144213048"],"Wikipedia":["Indole-3-acetic_acid"],"drugbank":["DB07950"],"chEBI":["16411"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94417","canonicalSmiles":"O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl","inchiKey":"YAWZIQKDHQIHOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL94417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02873"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
